Bibliographic record
Abstract
Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Magnus EkströmMagnus EkströmMagnus Ekström, MD, is a consultant and Associate Professor in respiratory medicine at Lund University, Sweden. He is the head of the Swedish National Registry for Respiratory Failure (Swedevox). His main research focus is breathlessness mechanisms, assessment and treatment. He also leads research in oxygen therapy and treatment in patients with chronic respiratory failure. He is involved in multiple multicenter studies, international research collaborations and lead projects across a range of research methodologies, including mechanistic, epidemiological, registry-based studies, clinical cohort studies, Cochrane meta-analyses, and randomized controlled trials. Morag FarquharMorag FarquharDr Farquhar has worked in health services research for over 30 years, predominantly in palliative and supportive care. She has worked for health authorities in London, and within the universities of London, Manchester, Cambridge and East Anglia (UEA), UK. An early graduate nurse by background (King's College London, UK), she holds a Masters in Medical Sociology and PhD (University of London) on the definition and measurement of quality of life in older people. Research interests include breathlessness in advanced disease, palliative care, informal carers, older people, and methodology – particularly the development and testing of interventions and mixed methods. As a Senior Lecturer at UEA, she leads a research programme on improving care and support for patients and carers living with advanced disease, including the Support Needs Approach for Patients programme (SNAP) and Learning about Breathlessness programme (LaB). SNAP has developed an intervention to enable person-centred care for people with chronic or progressive conditions (https://thesnap.org.uk), and LaB has developed a web-based educational intervention for carers of patients with breathlessness (https://supporting-breathlessness.org.uk/). These projects build on work conducted at University of Cambridge, UK as a Senior Research Associate and NIHR Career Development Fellow, including the Living with Breathlessness Study (patient and carer need and care preferences in advanced COPD), and as lead researcher on the RCT of the Cambridge Breathlessness Intervention Service, with Dr Sara Booth. Dr Farquhar has collaborated and published with colleagues in Canada and Australia in the field of breathlessness in advanced disease and palliative care methodology. In addition, she is the Associate Director of Research (Research Environment) for the School of Health Sciences. She also has a teaching role, including co-leading a post-registration module on Using Evidence to Lead and Advance Practice, and post-graduate supervision. Fred SaadFred SaadFred Saad, MD FRCS is Professor and Chairman of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers (CHUM), Canada. He holds the U of M Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer. He is the past Chair of the National Cancer Institute of Canada G-U Group and the Canadian Urologic Oncology Group. Dr Saad has been involved in most of the important clinical trials in advanced prostate cancer over the last 20 years and presently sits on seven steering committees of international clinical trials. He serves on several international guidelines committees and sits on seven editorial boards, including Lancet Oncology, JAMA Oncology, Nature Urology, and Urology, as well as Current Oncology. He has published over 400 peer-reviewed articles as well as over 1,500 scientific abstracts, eight books and over 50 book chapters. With a h-factor of 96 and over 41,000 citations he was listed as one of the most cited scientists in 2017. Dr Saad's research interests include molecular prognostic markers, mechanisms of progression, and new therapeutics in prostate cancer. He has over 40 clinical and basic research projects ongoing and has received over 30 million dollars in research grants to date. In 2014, he received the lifetime achievement award from the CHUM Research Center and in 2017 received the outstanding contribution award from The Prostate Cancer Canada Network. Andrea KokorovicAndrea KokorovicDr Kokorovic completed her undergraduate studies and a master's degree at the University of Toronto, Canada, followed by completing Medical School at Queen's University in Kingston, Ontario, Canada. She subsequently completed a urology residency at Dalhousie University in Halifax, Nova Scotia, Canada, followed by a fellowship in urologic oncology at The University of Texas MD Anderson Cancer Center, USA. She joined the University of Montreal, Canada, urology faculty as a urologic oncologist upon completing her fellowship in 2021. Her clinical and research interests include management of urologic cancers, with a focus on bladder, prostate, and kidney cancer. She is passionate about improving the lives of patients living with urological malignancies.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.007 | 0.063 |
| Meta-epidemiology (narrow) | 0.003 | 0.001 |
| Meta-epidemiology (broad) | 0.002 | 0.003 |
| Bibliometrics | 0.007 | 0.002 |
| Science and technology studies | 0.003 | 0.002 |
| Scholarly communication | 0.009 | 0.005 |
| Open science | 0.004 | 0.003 |
| Research integrity | 0.007 | 0.007 |
| Insufficient payload (model declined to judge) | 0.189 | 0.114 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".